We describe a patient with aggressive systemic inflammatory pseudotumor manifesting as isolated ocular myasthenia gravis. In this case, the routine chest imaging performed following the diagnosis of myasthenia gravis identified occult mediastinal lymphoid disease years prior to development of diffuse systemic symptoms.
Article InformationCorresponding Author: Marc H. Levin, MD, PhD, Department of Ophthalmology, University of California, San Francisco, 10 Koret Way, K203, San Francisco, CA 94143 (firstname.lastname@example.org).
Study concept and design: Levin, Galetta.
Acquisition of data: All authors.
Analysis and interpretation of data: All authors.
Drafting of the manuscript: Levin.
Critical revision of the manuscript for important intellectual content: All authors.
Administrative, technical, and material support: Levin, Gopal.
Study supervision: Galetta.
Conflict of Interest Disclosures: Dr Galetta has received consulting honoraria from Biogen Idec and Teva Pharmaceuticals. No other disclosures were reported.
Funding/Support: Dr Levin was supported by the Heed Ophthalmic Foundation.
Role of the Sponsor: The funding organization had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Previous Presentation: This paper was presented at the 39th Annual Meeting of the North American Neuro-Ophthalmology Society; February 10, 2013; Snowbird, Utah.